Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Co-Diagnostics, Inc. JV CoSara Receives Clearance From Indian Regulators For High-Risk HPV Multiplex Test

Co-Diagnostics, Inc.(NASDAQ: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd ("CoSara," or the "JV"), its joint venture for manufacturing and sales in India, has received clearance by the C
byHal Lindon
January 13, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Co-Diagnostics, Inc.(NASDAQ:CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its SARAGENE™ Human Papillomavirus High-Risk (HPV-HR) Real-Time PCR test as an in vitro diagnostic (“IVD”).

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Here’s How Much Investing $1,000 In Camber Energy Stock One Year Ago World Be Worth Today

By Wayne Duggan
October 28, 10:20 AM
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 33.6%. But there is no question some big-name stocks performed better than others along the way.

CEI